Literature DB >> 6720951

Intestinal transport of 5-methyltetrahydrofolate.

J Selhub, G M Powell, I H Rosenberg.   

Abstract

The mechanism of intestinal absorption of 5-methyltetrahydrofolate (5- CH3THF ) has been the topic of some controversy. In the present study, we have used enzymatically prepared 5- CH3THF to characterize transport by rat intestinal loops in vivo and everted jejunal sacs in vitro. Transport of 5- CH3THF is saturable (Km = 5.2 microM) and highly pH dependent, with the rate of maximal transport occurring at pH 5.8. Transport is competitively inhibited by folic acid (Ki = 4.2 microM) and methotrexate (Ki = 4.65 microM). Metabolic poisons and anaerobiosis greatly reduce 5- CH3THF transport. We conclude that 5- CH3THF transport in the rat intestine occurs by the same structure-specific mechanism responsible for the transport of unreduced folic acid and other monoglutamyl folates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6720951     DOI: 10.1152/ajpgi.1984.246.5.G515

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Food matrix structure (from Biscuit to Custard) has an impact on folate bioavailability in healthy volunteers.

Authors:  Caroline Buffière; Manon Hiolle; Marie-Agnès Peyron; Ruddy Richard; Nathalie Meunier; Cindy Batisse; Didier Rémond; Didier Dupont; Françoise Nau; Bruno Pereira; Isabelle Savary-Auzeloux
Journal:  Eur J Nutr       Date:  2020-05-03       Impact factor: 5.614

2.  Effect of folate-binding protein on intestinal transport of folic acid and 5-methyltetrahydrofolate across Caco-2 cells.

Authors:  Miriam Verwei; Henk van den Berg; Robert Havenaar; John P Groten
Journal:  Eur J Nutr       Date:  2004-08-17       Impact factor: 5.614

Review 3.  [Dietary folates--a timely review. Stability, physiological significance, bioavailability, analytical determination methods, effect of food handling].

Authors:  C Pfeiffer; J F Diehl; W Schwack
Journal:  Z Ernahrungswiss       Date:  1994-06

4.  FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS.

Authors:  Gino B Ferraro; Ahmed Ali; Alba Luengo; David P Kodack; Amy Deik; Keene L Abbott; Divya Bezwada; Landry Blanc; Brendan Prideaux; Xin Jin; Jessica M Posada; Jiang Chen; Christopher R Chin; Zohreh Amoozgar; Raphael Ferreira; Ivy X Chen; Kamila Naxerova; Christopher Ng; Anna M Westermark; Mark Duquette; Sylvie Roberge; Neal I Lindeman; Costas A Lyssiotis; Jens Nielsen; David E Housman; Dan G Duda; Elena Brachtel; Todd R Golub; Lewis C Cantley; John M Asara; Shawn M Davidson; Dai Fukumura; Véronique A Dartois; Clary B Clish; Rakesh K Jain; Matthew G Vander Heiden
Journal:  Nat Cancer       Date:  2021-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.